Search

everythinglearnresearchcommunity

for

Search:↓

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

S100A7 and IL-17 may contribute to inflammation in lichen planopilaris.

Blocking IL-17a can improve age-related smell loss in mice.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

Targeting IL-17 could help treat pattern hair loss.

Higher IL-17A levels indicate more severe alopecia areata.

A reliable method was created to measure dutasteride and related molecules in capsules.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

Clofazimine may be effective for treating ashy dermatosis.

Keratin 17 is modified by RSK1 in response to growth and stress, affecting skin growth and stress response.

Psoriasis patients' immune response to a hair protein depends on their specific gene type.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

Certain drugs that block specific enzymes can help treat prostate diseases.

Keratins 6, 16, and 17 increase in damaged or diseased skin and may help diagnose skin issues.

Chlormadinone acetate is useful for birth control and treating various hormonal issues.

Netherton syndrome has two subtypes with shared immune traits but different allergic and immune responses, suggesting targeted treatments.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

New acne treatments show promise as alternatives to traditional therapies.

Mesenchymal stem cells in people with Hidradenitis Suppurativa are more inflammatory, possibly contributing to the disease.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Secukinumab effectively treated a difficult case of folliculitis decalvans.

Hair follicles play a crucial role in regulating skin barrier function.

Secukinumab for psoriasis may cause hair loss.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

A medication may help with hair growth in psoriasis, and a skin condition might be linked to a specific bacteria.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

Researchers found a gene in hamsters that responds to male hormones and may be indirectly controlled by them.